First Time Loading...
A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 0.79 USD -8.73%
Updated: Apr 25, 2024

Intrinsic Value

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. [ Read More ]

The intrinsic value of one ASRT stock under the Base Case scenario is 1.26 USD. Compared to the current market price of 0.79 USD, Assertio Holdings Inc is Undervalued by 37%.

Key Points:
ASRT Intrinsic Value
Base Case
1.26 USD
Undervaluation 37%
Intrinsic Value
Price
A
Base Case Scenario

Valuation Backtest
Assertio Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ASRT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Assertio Holdings Inc

Provide an overview of the primary business activities
of Assertio Holdings Inc.

What unique competitive advantages
does Assertio Holdings Inc hold over its rivals?

What risks and challenges
does Assertio Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Assertio Holdings Inc recently?

Summarize the latest earnings call
of Assertio Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Assertio Holdings Inc.

Provide P/S
for Assertio Holdings Inc.

Provide P/E
for Assertio Holdings Inc.

Provide P/OCF
for Assertio Holdings Inc.

Provide P/FCFE
for Assertio Holdings Inc.

Provide P/B
for Assertio Holdings Inc.

Provide EV/S
for Assertio Holdings Inc.

Provide EV/GP
for Assertio Holdings Inc.

Provide EV/EBITDA
for Assertio Holdings Inc.

Provide EV/EBIT
for Assertio Holdings Inc.

Provide EV/OCF
for Assertio Holdings Inc.

Provide EV/FCFF
for Assertio Holdings Inc.

Provide EV/IC
for Assertio Holdings Inc.

Show me price targets
for Assertio Holdings Inc made by professional analysts.

What are the Revenue projections
for Assertio Holdings Inc?

How accurate were the past Revenue estimates
for Assertio Holdings Inc?

What are the Net Income projections
for Assertio Holdings Inc?

How accurate were the past Net Income estimates
for Assertio Holdings Inc?

What are the EPS projections
for Assertio Holdings Inc?

How accurate were the past EPS estimates
for Assertio Holdings Inc?

What are the EBIT projections
for Assertio Holdings Inc?

How accurate were the past EBIT estimates
for Assertio Holdings Inc?

Compare the revenue forecasts
for Assertio Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Assertio Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Assertio Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Assertio Holdings Inc compared to its peers.

Compare the P/E ratios
of Assertio Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Assertio Holdings Inc with its peers.

Analyze the financial leverage
of Assertio Holdings Inc compared to its main competitors.

Show all profitability ratios
for Assertio Holdings Inc.

Provide ROE
for Assertio Holdings Inc.

Provide ROA
for Assertio Holdings Inc.

Provide ROIC
for Assertio Holdings Inc.

Provide ROCE
for Assertio Holdings Inc.

Provide Gross Margin
for Assertio Holdings Inc.

Provide Operating Margin
for Assertio Holdings Inc.

Provide Net Margin
for Assertio Holdings Inc.

Provide FCF Margin
for Assertio Holdings Inc.

Show all solvency ratios
for Assertio Holdings Inc.

Provide D/E Ratio
for Assertio Holdings Inc.

Provide D/A Ratio
for Assertio Holdings Inc.

Provide Interest Coverage Ratio
for Assertio Holdings Inc.

Provide Altman Z-Score Ratio
for Assertio Holdings Inc.

Provide Quick Ratio
for Assertio Holdings Inc.

Provide Current Ratio
for Assertio Holdings Inc.

Provide Cash Ratio
for Assertio Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Assertio Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Assertio Holdings Inc?

What is the current Free Cash Flow
of Assertio Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Assertio Holdings Inc.

Financials

Balance Sheet Decomposition
Assertio Holdings Inc

Current Assets 171.1m
Cash & Short-Term Investments 73.4m
Receivables 47.7m
Other Current Assets 50m
Non-Current Assets 115.4m
PP&E 2m
Intangibles 111.3m
Other Non-Current Assets 2m
Current Liabilities 93.4m
Accounts Payable 13.4m
Accrued Liabilities 77.3m
Other Current Liabilities 2.7m
Non-Current Liabilities 55m
Long-Term Debt 38.5m
Other Non-Current Liabilities 16.5m
Efficiency

Earnings Waterfall
Assertio Holdings Inc

Revenue
152.1m USD
Cost of Revenue
-27m USD
Gross Profit
125m USD
Operating Expenses
-109m USD
Operating Income
16m USD
Other Expenses
-348m USD
Net Income
-331.9m USD

Free Cash Flow Analysis
Assertio Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ASRT Profitability Score
Profitability Due Diligence

Assertio Holdings Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
ROIC is Increasing
47/100
Profitability
Score

Assertio Holdings Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

ASRT Solvency Score
Solvency Due Diligence

Assertio Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
45/100
Solvency
Score

Assertio Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASRT Price Targets Summary
Assertio Holdings Inc

Wall Street analysts forecast ASRT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASRT is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

Lowest
Price Target
3.03 USD
284% Upside
Average
Price Target
3.06 USD
287% Upside
Highest
Price Target
3.15 USD
299% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ASRT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ASRT Price
Assertio Holdings Inc

1M 1M
-24%
6M 6M
-63%
1Y 1Y
-85%
3Y 3Y
-65%
5Y 5Y
-95%
10Y 10Y
-99%
Annual Price Range
0.79
52w Low
0.754
52w High
7.66
Price Metrics
Average Annual Return -6.62%
Standard Deviation of Annual Returns 70.1%
Max Drawdown -96%
Shares Statistics
Market Capitalization 74.8m USD
Shares Outstanding 95 000 000
Percentage of Shares Shorted 11.05%

ASRT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Assertio Holdings Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

74.8m USD

Dividend Yield

0%

Description

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

Contact

ILLINOIS
Lake Forest
100 S. Saunders Road, Suite 300
+12244197106.0
https://www.assertiotx.com/

IPO

1997-02-12

Employees

19

Officers

Interim CEO & Director
Ms. Heather L. Mason
Senior VP & CFO
Mr. Ajay Patel
Senior Vice President & Chief Commercial Officer
Mr. Paul Schwichtenberg
Senior Vice President of Operations
Mr. Bill Iskos
Senior Vice President of HR & Administration ?
Ms. Molly Dir
Senior VP & General Counsel
Mr. Sam Schlessinger
Show More
Senior Vice President of Medical
Dr. Howard J. Franklin M.B.A., M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ASRT stock?

The intrinsic value of one ASRT stock under the Base Case scenario is 1.26 USD.

Is ASRT stock undervalued or overvalued?

Compared to the current market price of 0.79 USD, Assertio Holdings Inc is Undervalued by 37%.